On a Holm-related MTP for rejecting at least <i>k</i> hypotheses: general validity, optimality property, confidence regions, and applications

This article concerns <i>p</i>-value-based multiple testing procedures (MTPs) that can be used in a confirmatory clinical study under minimal assumptions in case the requirement for study-success is that at least <i>k</i> out of <i>m</i> primary/important hypotheses become rejected. Recently, a simple, generally valid Holm-type MTP was discussed that can be used for such a requirement for any <i>k</i> from one to <i>m</i>. It can only reject at least <i>k</i> (or zero) hypotheses, but this increases the power to reject <i>k</i> or more hypotheses compared to Holm's step-down MTP. The present article provides a simple formulation and proof of strong family-wise error rate (FWER) control for a stepwise MTP that is sharper in that for any <i>k</i> strictly between one and <i>m</i> it: (a) always rejects at least as much, and (b) can potentially reject fewer than <i>k</i> hypotheses. This sharper MTP too is generally valid, without any assumption about logical or stochastic relationships. It has a gatekeeping step, followed by <i>m</i> steps where ordered primary <i>p</i>-values are compared to critical constants and rejections are made in a step-down manner. These constants have the optimality property that under a natural monotonicity restriction, they cannot be increased without losing the general strong FWER control. Confidence regions like those for Holm's MTP are provided. Applications are discussed in connection with three interesting approaches proposed earlier for confirmatory studies: (a) the Superiority-Noninferiority approach; (b) Fallback tests for co-primary endpoints; and (c) Multistage gatekeeping MTPs that utilize so-called <i>k</i>-truncated Holm MTPs in some stages.

Authors

Publication Details

Journal
Journal of Biopharmaceutical Statistics
Published
2024-12-18
DOI
https://doi.org/10.1080/10543406.2024.2429478
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

On a Holm-related MTP for rejecting at least k hypotheses: general validity, optimality property, confidence regions, and applications

Olivier Guilbaud
Journal of Biopharmaceutical Statistics
Statistical Methods in Clinical Trials
article

On a Holm-related MTP for rejecting at least k hypotheses: general validity, optimality property, confidence regions, and applications

Olivier Guilbaud
article en

Abstract

This article concerns <i>p</i>-value-based multiple testing procedures (MTPs) that can be used in a confirmatory clinical study under minimal assumptions in case the requirement for study-success is that at least <i>k</i> out of <i>m</i> primary/important hypotheses become rejected. Recently, a simple, generally valid Holm-type MTP was discussed that can be used for such a requirement for any <i>k</i> from one to <i>m</i>. It can only reject at least <i>k</i> (or zero) hypotheses, but this increases the power to reject <i>k</i> or more hypotheses compared to Holm's step-down MTP. The present article provides a simple formulation and proof of strong family-wise error rate (FWER) control for a stepwise MTP that is sharper in that for any <i>k</i> strictly between one and <i>m</i> it: (a) always rejects at least as much, and (b) can potentially reject fewer than <i>k</i> hypotheses. This sharper MTP too is generally valid, without any assumption about logical or stochastic relationships. It has a gatekeeping step, followed by <i>m</i> steps where ordered primary <i>p</i>-values are compared to critical constants and rejections are made in a step-down manner. These constants have the optimality property that under a natural monotonicity restriction, they cannot be increased without losing the general strong FWER control. Confidence regions like those for Holm's MTP are provided. Applications are discussed in connection with three interesting approaches proposed earlier for confirmatory studies: (a) the Superiority-Noninferiority approach; (b) Fallback tests for co-primary endpoints; and (c) Multistage gatekeeping MTPs that utilize so-called <i>k</i>-truncated Holm MTPs in some stages.

Journal of Biopharmaceutical Statistics
Openalex Percentile: Top 76%
Statistical Methods in Clinical Trials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.